The vaccine manufacturer Johnson & Johnson is having delivery problems.
A production downtime and export restrictions are said to be the reason.
Brussels / Leiden - According to information from EU circles, the US manufacturer Johnson & Johnson has delivery problems with its corona vaccine. The 55 million vaccine doses expected for the second quarter would probably not be reached, the
German press agency
learned
on Thursday in Brussels. The background to this is an already known loss of production in the USA and export restrictions by the US authorities for finished and packaged vaccines.
Johnson & Johnson is one of four manufacturers with EU approval for corona vaccine.
Since, in contrast to other vaccines, only one syringe is sufficient for immunization, the vaccine is particularly important for the vaccination campaign.
The vaccine plays a central role in vaccination in socially disadvantaged areas.
The Federal Ministry of Health expects a good 10 million vaccine doses for Germany from April to the end of June and has not yet changed this forecast.
Delivery problems at Johnson & Johnson: The cut should be offset later
A spokesman for the EU Commission officially stated that the member states had been informed of delays by the European Johnson & Johnson subsidiary Janssen.
It is a matter of a temporary reduction in the delivery, which is later offset.
It is also assumed that the manufacturers will deliver enough corona vaccine by July to vaccinate 70 percent of adults in the EU.
Video: Corona current: The vaccination update for Germany
The US manufacturer's delivery bottlenecks were also an issue at the vaccination summit on Thursday.
At the press conference following the Prime Minister's Conference, Chancellor Angela Merkel affirmed that the promise of vaccinations to all German citizens could be maintained until the end of the summer.
In addition, young people between the ages of twelve and 16 will probably also be vaccinated from June 7th.
The decisive decision of the European Medicines Agency is expected for Friday.
Biontech also announced on Wednesday that it had to temporarily reduce the amount of its vaccine delivered. (Dpa / fmü)